Biocytogen conclut un accord sur les anticorps avec Merck ...Middle East

BEIJING, 30 avril 2022 /PRNewswire/ -- Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen) a annoncé avoir conclu un accord d'évaluation et d'option avec Merck afin de leur accorder une licence unique pour évaluer les anticorps exclusifs de Biocytogen contre au moins trois cibles...

Hence then, the article about biocytogen conclut un accord sur les anticorps avec merck was published today ( Saturday 30/04/2022 - 05:42 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Biocytogen conclut un accord sur les anticorps avec Merck )

Also on site :

• Anycubic Opens Deposits for Kobra X, Following Formnext Debut of Its Next-Generation Entry-Level Multicolor FDM Printer
• Numbrix 9 - December 26
• Outsiders see a circular economy. CoreWeave’s CEO sees a ‘violent change’ rattling the supply chain down to the inside of the earth